- Home
- ACTG vs NPCE Comparison
ACTG vs NPCE Comparison
Compare ACTG & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- NPCE
- Stock Information
- Founded
- ACTG 1993
- NPCE 1997
- Country
- ACTG United States
- NPCE United States
- Employees
- ACTG 1036
- NPCE N/A
- Industry
- ACTG Multi-Sector Companies
- NPCE Medical Specialities
- Sector
- ACTG Miscellaneous
- NPCE Health Care
- Exchange
- ACTG Nasdaq
- NPCE Nasdaq
- Market Cap
- ACTG 314.4M
- NPCE 292.9M
- IPO Year
- ACTG 1996
- NPCE 2021
- Fundamental
- Price
- ACTG $3.34
- NPCE $8.99
- Analyst Decision
- ACTG
- NPCE Strong Buy
- Analyst Count
- ACTG 0
- NPCE 6
- Target Price
- ACTG N/A
- NPCE $16.67
- AVG Volume (30 Days)
- ACTG 234.8K
- NPCE 205.6K
- Earning Date
- ACTG 08-06-2025
- NPCE 08-12-2025
- Dividend Yield
- ACTG N/A
- NPCE N/A
- EPS Growth
- ACTG N/A
- NPCE N/A
- EPS
- ACTG N/A
- NPCE N/A
- Revenue
- ACTG $247,813,000.00
- NPCE $88,570,000.00
- Revenue This Year
- ACTG $141.36
- NPCE $21.04
- Revenue Next Year
- ACTG N/A
- NPCE $10.73
- P/E Ratio
- ACTG N/A
- NPCE N/A
- Revenue Growth
- ACTG 62.44
- NPCE 23.32
- 52 Week Low
- ACTG $2.70
- NPCE $5.45
- 52 Week High
- ACTG $5.36
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- ACTG 43.82
- NPCE 48.24
- Support Level
- ACTG $3.17
- NPCE $8.17
- Resistance Level
- ACTG $3.50
- NPCE $8.73
- Average True Range (ATR)
- ACTG 0.15
- NPCE 0.56
- MACD
- ACTG -0.00
- NPCE 0.07
- Stochastic Oscillator
- ACTG 38.60
- NPCE 67.44
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.